David A. Siegel Celcuity Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Celcuity Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 55,000 shares of CELC stock, worth $685,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,000
Previous 19,700
179.19%
Holding current value
$685,300
Previous $322,000
154.66%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CELC
# of Institutions
107Shares Held
30.3MCall Options Held
30.8KPut Options Held
152K-
Bvf Inc San Francisco, CA3.47MShares$43.2 Million1.64% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$29.4 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$23.4 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$20.3 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.54MShares$19.1 Million0.4% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $186M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...